Skip to main content
. Author manuscript; available in PMC: 2010 Feb 3.
Published in final edited form as: J Am Coll Cardiol. 2009 Feb 3;53(5 Suppl):S35–S42. doi: 10.1016/j.jacc.2008.09.055

Table 2.

Examples of Mechanisms Implicated in Diabetic Microvascular Disease

Risk factors: Hyperglycemia
Targets: Endothelium, Podocytes, Pericytes, VSMCs
Increased aldose
reductase pathway
Protein kinase
activation
Increased
oxidative
stress
Protein
glycation
Increased
hexosamine
pathway

↑Sorbitol: Osmotic cellular damage
↓(Na+ & K+) ATPase activity
↑NADH/NAD+
↓NADPH
↑VEGF
↑ROS
NF-κB activation
Inhibition of eNOS activity
↑Endothelin-1
↑ROS ↑AGE
Apoptotic death
NFκB activation
↑ROS
↑PAI-1
Inhibition of eNOS activity

VSMCs = vascular smooth muscle cells; eNOS = endothelial nitric oxide synthase; NAD = nicotine adenine dinucleotide; NADH = nicotine adenine dinucleotide reduced; NADPH = nicotine adenine dinucleotide phosphate reduced; PAI-1 = plasminogen activator inhibitor-1; ROS = reactive oxygen species; VEGF = vascular endothelial growth factor; other abbreviations as in Table 1.